CERULEAN PHARMA INC Chart calendar Cerulean Pharma Inc
aa0bd1ec695b1b25bbb.UnIRxvacuBmC52Y84MXtsKHyJ-TD6ASgnqLvx9RW4NQ.HhRzp7zs52zTsT5Xlaa98cnBU4u2sU_2rcvakbYxtLU8S3C3kO3hc-uXJw~8931234bccb20e67eaff5c99fcfdd25e
Upcoming events on Cerulean Pharma Inc
Past events on Cerulean Pharma Inc
| Today | Q1 2024 Earnings Release |
| 28/03/2024 20:30 | Q4 2023 Earnings Call |
| 28/03/2024 12:00 | Q4 2023 Earnings Release |
| 24/02/2024 18:05 | Society for the Study of Women Sexual Health International Meeting - Impact of Enrollment Diagnosis |
| 24/02/2024 18:05 | Society for the Study of Women Sexual Health International Meeting - Sexual Experiences in an Explor |
| 24/02/2024 18:05 | Society for the Study of Women Sexual Health International Meeting - Female Sexual Distress in an Ex |
| 18/11/2023 21:30 | Sexual Medicine Society of North America Fall Scientific Meeting |
| 14/11/2023 21:45 | Stifel Healthcare Conference |
| 10/11/2023 17:00 | Collaborating for Novel Solutions Summit |
| 09/11/2023 21:30 | Q3 2023 Earnings Call |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 30/09/2023 14:35 | North American Menopause Society Meeting - Study to Evaluate the Preliminary Efficacy and Usability |
| 30/09/2023 14:35 | North American Menopause Society Meeting - Study to Evaluate the Safety and Pharmacokinetics |
| 30/09/2023 14:35 | North American Menopause Society Meeting - Safety and Preliminary Pharmacodynamic Evaluation |
| 26/09/2023 14:20 | Cantor Global Healthcare Conference |
| 11/09/2023 18:30 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
| 10/08/2023 13:00 | Q2 2023 Earnings Release |
| 13/07/2023 | International Symposium |
| 11/07/2023 21:30 | Investor Meeting - Key Opinion Leaders |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,65 - | 0,00 1,25 - | 10,0 10,0 0% | 2,81 2,12 32.62% | 15,6 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,3 -14,3 -0.46% | -27,4 -25,6 -7.05% | -39,1 -42,6 8.19% | -31,4 -25,9 -21.4% | -30,9 -34,3 9.74% | -18,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,3 -14,6 2.28% | -27,4 -25,6 -7.18% | -38,7 -41,2 5.99% | -30,9 -23,8 -29.94% | -30,2 -33,5 9.92% | -17,8 |
|
Net income Million USD | Released Forecast Spread | -15,1 -14,8 -1.82% | -27,4 -25,9 -6.01% | -38,7 -35,7 -8.39% | -30,9 -25,7 -20.37% | -30,2 -33,5 10% | -17,8 |
|
EPS USD | Released Forecast Spread | -0,97 -0,95 -2.37% | -0,91 -0,87 -5.2% | -0,63 -0,60 -5% | -0,37 -0,31 -21.31% | -0,35 -0,37 4.55% | -0,16 |
| Announcement Date | 27/03/20 | 30/03/21 | 31/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 1,25 - | 0,00 0,00 - | 10,0 6,67 50% | 0,00 2,65 - | 0,00 0,00 - | 0,00 2,50 - | 0,00 0,90 - | 1,00 0,39 159.29% | 1,81 1,45 24.63% | 0,26 | 13,0 | 4,80 | 4,09 | |
|
EBIT Million USD | Released Forecast Spread | -9,54 -13,0 26.75% | -8,40 -12,5 32.53% | 0,38 -5,55 106.92% | -7,14 -9,84 27.42% | -16,2 -10,7 -51.7% | -8,38 -12,0 30.07% | -8,99 -7,97 -12.83% | -8,40 -8,90 5.68% | -5,17 -8,49 39.11% | -6,33 | 5,80 | -4,92 | -4,61 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,54 -11,9 19.7% | -8,40 -13,4 37.39% | 0,41 -8,71 104.75% | -7,02 -9,47 25.84% | -15,9 -8,76 -81.94% | -8,04 -12,0 32.91% | -8,76 -7,90 -10.91% | -8,30 -8,77 5.37% | -5,06 -8,38 39.62% | -6,19 | 5,92 | -4,87 | -4,46 | |
|
Net income Million USD | Released Forecast Spread | -9,54 -13,0 26.75% | -8,40 -11,6 27.49% | 0,41 -5,55 107.46% | -7,02 -9,83 28.56% | -15,9 -10,7 -49.45% | -8,04 -12,0 32.91% | -8,76 -7,90 -10.91% | -8,30 -8,77 5.37% | -5,06 -8,38 39.62% | -6,19 | 5,92 | -4,87 | -4,46 | |
|
EPS USD | Released Forecast Spread | -0,18 -0,18 0% | -0,10 -0,14 30.23% | 0,00 -0,06 107.74% | -0,08 -0,11 29.41% | -0,19 -0,13 -52% | -0,09 -0,10 10% | -0,10 -0,09 -11.11% | -0,09 -0,10 10% | -0,06 -0,08 25% | -0,06 | 0,06 | -0,04 | -0,04 | 0,00 |
| Announcement Date | 31/03/22 | 12/05/22 | 09/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 15/05/2024 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 20/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
